Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus

Urothelial carcinoma of the bladder (UCB) is the most common malignancy of the urinary tract, nearly half of which contains a mutation in TP53 gene. Hence, therapeutic approach by restoring functional p53 protein in cancer cells will be beneficial. Recent studies have demonstrated the inhibition of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Wu, Kaijie, Ding, Chen, Sun, Kangwei, Guan, Zhenfeng, Wang, Xinyang, Hsieh, Jer-Tsong, He, Dalin, Fan, Jinhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741965/
https://www.ncbi.nlm.nih.gov/pubmed/26462022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741965/
https://www.ncbi.nlm.nih.gov/pubmed/26462022

Ejemplares similares